Advancing Rapid Disease Detection in the China Point of Care Molecular Diagnostics Market
The China Point of Care Molecular Diagnostics Market is on the verge of remarkable growth. By 2035, the market size is projected to reach approximately $1,124.1 million, reflecting an impressive compound annual growth rate (CAGR) of 8.28% from its current valuation of $432.75 million. This accelerated growth can largely be attributed to the increasing prevalence of infectious diseases combined...
0 Kommentare 0 Geteilt 2 Ansichten 0 Bewertungen